James Bristol
Chairman
Ernexa Therapeutics Inc. (ERNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ERNA alertsAbout James Bristol
James Bristol is recorded as Chairman at Ernexa Therapeutics Inc. (ERNA). The newest filing on record that lists James Bristol as Chairman at Ernexa Therapeutics Inc. (ERNA) is dated May 11, 2026. Ernexa Therapeutics Inc. reported in an 8-K filed December 20, 2023 that James Bristol was appointed chairman of the Board, effective December 19, 2023. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.
“On December 19, 2023, the Board appointed James Bristol as chairman of the Board, effective immediately, to serve until his successor is duly elected and qualified, or until his earlier resignation or removal.”
Affiliation history
-
Current
Start not stated–present
Last confirmed May 11, 2026
Company network
Leadership on record at Ernexa Therapeutics Inc.
- Dr. Matthew Angel CEO
- Matt Angel, Ph.D. CEO
- Sanjeev Luther CEO, Board Member
- Allen Wolff Chairman, Board Member
- Luba Greenwood Chairman, Board Member
- Sandra Gurrola CFO
- Dorothy Clarke General Counsel
- Brant C. Binder Board Member
- Dennis H. Langer Board Member
- Dorothy J. Clarke Board Member